Skip to main content
. 2020 Apr 14;6:11. doi: 10.1186/s41016-020-00190-5

Table 1.

Clinical characteristics of subjects in this study

Group N Sex (M/F) Age Histology#
Discovery phase
Gliomas 5 2/3 45.20 ± 10.50 WHO-II (1); WHO-IV (4)
Validation phase
Gliomas 10 6/4 44.78 ± 12.20 WHO-II (2); WHO-III (2); WHO-IV(6)
Meningioma 5 2/3 54.60 ± 9.42 --
Moyamoya 6 3/3 37.67 ± 9.69 --
Healthy control 12 5/7 42.17 ± 8.42 --

Glioma grade classified as World Health Organization (WHO) grades I–IV

M male; F female